| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |